Clinical Trials
Acute Promyelocytic Leukemia and KS Data Reported
Published in Cancer Weekly, April 14th, 1997
The companies also announced that they have amended their agreement relating to Atragen. Preliminary safety data from an ongoing Phase II trial in APL indicate that Atragen was well tolerated, and reflected results obtained in the Phase I maximum tolerated dose trial. One hundred percent of first relapse patients (10 out of 10) have achieved a complete remission with Atragen monotherapy.
"At the end of 1997, we expect to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1997-04-14)
More Articles from Cancer Weekly
- Cancer Gene Therapy
Canarypox Virus-Mediated Immunotherapy: Success In Vivo - Breast Cancer
More Accurate Cancer Diagnosis Advances Reported - Breast Cancer (California)
Bill Clears Way To Lifesaving Breast-Cancer Treatment - Cancer (Detection)
Technologies Featured at Annual Meeting - Cancer Gene Therapy
Tumor Transfection with Nitric Oxide Gene Exhibits Bystander Effect - Cancer Gene Therapy (Immunotherapy)
IL-2 Transduced Tumor Cells Effective Against Pancreatic Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
